Mita Kuchimanchi Selected Research

Mita Kuchimanchi Research Topics

2	Neoplasms (Cancer) 10/2013 - 11/2010
1	Multiple Sclerosis 03/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Residual Neoplasm 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2020
1	Cytokine Release Syndrome 01/2019
1	Hypercholesterolemia 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Secondary Hyperparathyroidism 06/2015
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2013
1	Ovarian Neoplasms (Ovarian Cancer) 05/2012
1	medullary Thyroid cancer 11/2010
1	Thyroid Neoplasms (Thyroid Cancer) 11/2010

4	Monoclonal AntibodiesIBA 01/2020 - 10/2013
2	blinatumomabIBA 01/2020 - 01/2019
1	diroximel fumarateIBA 03/2022
1	monomethyl fumarateIBA 03/2022
1	succinimideIBA 03/2022
1	FumaratesIBA 03/2022
1	SynucleinsIBA 01/2020
1	evolocumabIBA 01/2018
1	oxidized low density lipoproteinIBA 01/2018
1	Proprotein Convertase 9IBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Capecitabine (Xeloda)FDA Link 01/2017
1	Epirubicin (Ellence)FDA LinkGeneric 01/2017
1	rilotumumabIBA 01/2017
1	Calcium-Sensing ReceptorsIBA 06/2015
1	etelcalcetide hydrochlorideIBA 06/2015
1	Gemcitabine FDA Link 10/2013
1	ganitumabIBA 10/2013
1	Insulin (Novolin)FDA Link 10/2013
1	CreatinineIBA 10/2013
1	AlbuminsIBA 10/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2012
1	trebananibIBA 05/2012
1	Pharmaceutical PreparationsIBA 11/2010
1	motesanib diphosphateIBA 11/2010

1	Oral Administration 03/2022
1	Drug Therapy (Chemotherapy) 01/2019
1	Renal Dialysis (Hemodialysis) 06/2015
1	Therapeutics 12/2014